Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.82 |
| ▸ | ESR1 | P03372 | 5/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.82 |
| ▸ | PGR | P06401 | 2/20 | 0.82 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.82 |
| ▸ | AR | P10275 | 2/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.82 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 1/20 | 0.82 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.82 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.82 |
| ▸ | ATM | Q13315 | 1/20 | 0.82 |
| ▸ | USP2 | O75604 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Estradiol Propionate SCHEMBL26659949 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL30165166 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL30384276 | 1.00 | MAPT (1.00) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL28094685 | 0.98 | MAPT (0.96) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL28092621 | 0.95 | MAPT (0.91) | MAPTKMT2AMEN1CYP3A4TP53 | |
| Estradiol Propionate SCHEMBL27583398 | 0.93 | MAPT (0.86) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL9404746 | 0.92 | MAPT (0.89) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL19393249 | 0.92 | MAPT (0.89) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL822184 | 0.92 | MAPT (0.85) | MAPTKMT2AMEN1CYP3A4TP53 | |
| SCHEMBL19286812 | 0.92 | MAPT (0.85) | MAPTKMT2AMEN1CYP3A4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180171288-A1 | METHODS OF TREATING CANCER | UNIVERSITY OF ROCHESTER | 2018-06-21 | — | — | US | claimed |
| US-8110565-B2 | Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release | NOVEN PHARMACEUTICALS, INC. (US) | 2012-02-07 | — | — | US | claimed |
| EP-1406633-B1 | ENHANCED DRUG DELIVERY IN TRANSDERMAL SYSTEMS | NOVEN PHARMA (US) | 2011-10-05 | — | — | EP | claimed |
| US-20110097405-A1 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-04-28 | — | — | US | claimed |
| US-7846916-B2 | Enhanced drug delivery in transdermal systems | Noven Pharamaceticals, Inc. (US) | 2010-12-07 | — | — | US | claimed |
| EP-2249803-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-11-17 | — | — | EP | claimed |
| WO-2009101021-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-08-20 | — | — | WO | claimed |
| CN-101426475-A | Methods of treating hot flashes with formulations for transdermal or transmucosal application | ANTARES PHARMA IPL AG (CH) | 2009-05-06 | — | — | CN | claimed |
| US-20080167280-A1 | Enhanced drug delivery in transdermal systems | NOVEN PHARMACEUTICALS, INC. | 2008-07-10 | — | — | US | claimed |
| CN-100391462-C | Enhanced drug delivery in transdermal systems | NOVEN PHARMA (US) | 2008-06-04 | — | — | CN | claimed |
| EP-0256668-B1 | METHOD FOR TREATING MALE SEXUAL DYSFUNCTION | UNIVERSITY OF FLORIDA (US) | 1992-11-04 | — | — | EP | claimed |
| EP-0500793-A1 | OSMOTIC, ORAL DOSAGE FORM FOR FERTILITY CONTROL. | ALZA CORP (US) | 1992-09-02 | — | — | EP | claimed |
| US-5098714-A | OSMOTIC, ORAL DOSAGE FORM FOR FERTILITY CONTROL | ALZA CORPORATION (US) | 1992-03-24 | — | — | US | claimed |
| WO-1991007173-A1 | OSMOTIC, ORAL DOSAGE FORM FOR FERTILITY CONTROL | ALZA CORPORATION (US) | 1991-05-30 | — | — | WO | claimed |
| US-4948593-A | SUSTAINED AND CONTROLLED CONTRACEPTION | ALZA CORPORATION (US) | 1990-08-14 | — | — | US | claimed |
| US-4863911-A | Method for treating male sexual dysfunction | UNIVERSITY OF FLORIDA (US) | 1989-09-05 | — | — | US | claimed |
| EP-0256668-A2 | Method for treating male sexual dysfunction | UNIVERSITY OF FLORIDA (US) | 1988-02-24 | — | — | EP | claimed |
| EP-0220844-A2 | Use of estrogen-dihydropyridine compounds for weight control | UNIVERSITY OF FLORIDA (US) | 1987-05-06 | — | — | EP | claimed |
| US-4617298-A | STEROIDS | UNIVERSITY OF FLORIDA (US) | 1986-10-14 | — | — | US | claimed |
| US-4014987-A | VAGINAL DEVICE; USING A HYDROPHOBIC POLYCARBOXYLIC ACID AS DRUG RELEASE RATE CONTROLLER | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |